New psychoactive substances (NPS) are a heterogeneous group of substances. They are
associated with a number of health and social harms on an individual and societal level …

We did a global review to synthesise data on the prevalence, harms, and interventions for
stimulant use, focusing specifically on the use of cocaine and amphetamines. Modelling …

We summarise the evidence for medicinal uses of opioids, harms related to the extramedical
use of, and dependence on, these drugs, and a wide range of interventions used to address …

Purpose The emergence of novel psychoactive substances (NPS) has been being a
continuous and evolving problem for more than a decade. Every year, dozens of new …

Synthetic cannabinoid receptor agonists (SCRAs) are an evolving class of new psychoactive
substances (NPS) with structurally diverse compounds emerging each year. Due to the rapid …

Aims: The harms arising from psychoactive drug use are complex, and harm reduction
strategies should be informed by a detailed understanding of the extent and nature of that …

The proliferation of new psychoactive substances (NPS) over recent years has made their
surveillance complex. The analysis of raw municipal influent wastewater can allow a …

Abstract SARS-CoV-2, the virus that causes COVID-19, has changed the world as we know
it, and continues to do so. How COVID-19 affects people who use drugs, the environments in …

Forensic Chemistry, Third Edition, the new edition of this ground-breaking book, continues to
serve as the leading forensic chemistry text on the market. Fully updated, this edition …

Over the past decade, the illicit drug market has been reshaped by the proliferation of
clandestinely produced designer drugs. These agents, referred to as new psychoactive …